3 completed, 1 unknown. 2 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Unknown 1 |
Follow AC133 Antigen: new trials by email Literature Review of AC133 Antigen trials Research Report on AC133 Antigen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty G-CSF + CD133(+) cells, G-CSF, percutaneous transluminal angioplasty (PTA) - Peripheral Arterial Disease | Phase 1 | Unknown | Shanghai 10th People's Hospital | 345 | 2016-09-01 | 2016-09-28 |
| IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting Injection of autologous CD133+ stem cells at the time of coronary artery bypass grafting - Heart Failure, Heart Attack | Phase 2 | Completed | University Health Network, Toronto | 20 | 2011-09-01 | 2015-12-02 |
| Bone Marrow Derived AC 133+ and Mono-Nuclear Cells (MNC) Implantation in Myocardial Infarction (MI) Patient AC133, MNC, CONTROL - Myocardial Infarction | Phase 2 / Phase 3 | Completed | Royan Institute | 80 | 2009-05-01 | 2012-12-27 |
| Autologous Bone Marrow Derived Stem Cells for Acute Myocardial Infarction MNC, AC 133, Control - Myocardial Infarction | Phase 3 | Completed | Royan Institute | 90 | 2008-01-01 | 2016-06-21 |
Myocardial Infarction (3) · Heart Failure (1) · Peripheral Arterial Disease (1)
Royan Institute (2) · Shanghai 10th People's Hospital (1) · University Health Network, Toronto (1)
Iran (2) · Canada (1) · China (1)
Hamid Gourabi, PhD (2) · Hossein Baharvand, PhD (2) · Masoud Ghassemi, MD (1) · Mohammadhassan Nasseri, MD (1) · Nasser Aghdami, MD, PhD (1) · Nasser Aghdami, PhD,MD (1) · Terrence M Yau, MD (1)